XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.3
The Company and Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Summary of Cash and Cash Equivalents and Restricted Cash

The Company's cash and cash equivalents and restricted cash, as presented in the Consolidated Statements of Cash Flows, was as follows (in thousands):

 

 

As of

 

 

September 30,

 

 

2023

 

 

2022

 

Cash and cash equivalents

$

110,624

 

 

$

121,589

 

Restricted cash

 

765

 

 

 

751

 

Total as presented in the Consolidated Statements of Cash Flows

$

111,389

 

 

$

122,340

 

Summary of Non-Vested Restricted Stock Units Granted

The following is a summary of non-vested restricted stock units granted (in thousands, except grant date fair value data):

 

 

 

Three-Month Period

 

 

Nine-Month Period

 

 

 

 

Ended September 30,

 

 

Ended September 30,

 

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

Restricted stock units granted

 

 

1,000

 

 

 

-

 

 

 

4,813

 

 

175

 

 

Weighted average fair value

 

$

4.39

 

 

$

-

 

 

$

6.08

 

 

$

5.41

 

 

Summary Of Valuation Model At The Time Of Award Issuance The unobservable significant inputs to the valuation model at the time of award issuance were as follows:

 

 

 

 

 

Stock price at issuance

 

$

4.39

 

Expected volatility

 

 

58.0

%

Risk-free interest rate

 

 

4.13

%

Expected term

 

 

5.0

 

Expected dividend yield

 

 

0

%

Summary of Non-Vested PSU Activity

During the nine-month period ended September 30, 2023, the Company had the following non-vested PSUs activity (in thousands, except grant date fair value data):

 

 

 

Number of PSUs

 

 

Weighted-Average Grant Date Fair Value

 

Nonvested balance at December 31, 2022

 

 

-

 

 

$

-

 

Granted

 

 

1,000

 

 

 

3.29

 

Vested

 

 

-

 

 

 

-

 

Forfeited or cancelled

 

 

-

 

 

 

-

 

Nonvested balance at September 30, 2023

 

 

1,000

 

 

 

3.29

 

Reconciliation of Basic and Diluted Income (Loss) Per Share

The following table illustrates the reconciliation of the basic and diluted income (loss) per share (in thousands, except share and per share data):

 

 

Three-Month Period

 

 

Nine-Month Period

 

 

 

Ended September 30,

 

 

Ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Basic earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to common stockholders

 

$

2,719

 

 

$

9,393

 

 

$

2,771

 

 

$

19,747

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

87,995,567

 

 

 

84,945,873

 

 

 

87,803,770

 

 

 

85,469,675

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Per share:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share attributable to common stockholders

 

$

0.03

 

 

$

0.11

 

 

$

0.03

 

 

$

0.23

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to common stockholders

 

$

2,719

 

 

$

9,393

 

 

$

2,771

 

 

$

19,747

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

87,995,567

 

 

 

84,945,873

 

 

 

87,803,770

 

 

 

85,469,675

 

Dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Stock options and restricted stock units

 

 

1,893,154

 

 

 

2,471,628

 

 

 

2,031,593

 

 

 

2,202,051

 

Diluted shares outstanding

 

 

89,888,721

 

 

 

87,417,501

 

 

 

89,835,363

 

 

 

87,671,726

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Per share:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share attributable to common stockholders

 

$

0.03

 

 

$

0.11

 

 

$

0.03

 

 

$

0.23

 

Fair Value of Assets and Liabilities Measured on Recurring Basis and Nonrecurring Basis

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring and nonrecurring basis in the condensed consolidated balance sheets (in millions):

 

September 30, 2023

Total Fair Value

and Carrying

Value on

Balance Sheet

Fair Value Measurement Category

 

 

 

 Recurring fair value measurements

Level 1

Level 2

Level 3

 

 

Total Gains (Losses)

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market account

 

$

0.4

 

 

$

0.4

 

 

$

 

 

$

 

 

 

 

Corporate bonds and notes

 

$

17.4

 

 

 

 

 

$

17.4

 

 

 

 

 

 

 

Asset-backed securities

 

$

0.6

 

 

 

 

 

$

0.6

 

 

 

 

 

 

 

U.S. Government securities

 

$

0.1

 

 

 

 

 

$

0.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

 

$

21.6

 

 

$

 

 

 

 

 

$

21.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2022

Total Fair Value

and Carrying

Value on

Balance Sheet

Fair Value Measurement Category

 

 

 

 Recurring fair value measurements

Level 1

Level 2

Level 3

 

 

Total Gains (Losses)

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market account

 

$

1.4

 

 

$

1.4

 

 

$

 

 

$

 

 

 

 

Corporate bonds and notes

 

$

44.5

 

 

 

 

 

$

44.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

 

$

63.8

 

 

$

 

 

 

 

 

$

63.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nonrecurring fair value measurements:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FCC licenses

 

$

24.5

 

 

 

 

 

 

 

 

$

24.5

 

$

(1.6

)

Summary of Amortized Cost and Unrealized Gains (Losses) of Available for Sale Securities

As of September 30, 2023, the following table summarizes the amortized cost and the unrealized gains (losses) of the available for sale securities (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate Bonds and Notes

 

 

Asset-Backed Securities

 

 

U.S. Government securities

 

 

 

Amortized Cost

 

 

Unrealized gains (losses)

 

 

Amortized Cost

 

 

Unrealized gains (losses)

 

 

Amortized Cost

 

 

Unrealized gains (losses)

 

Due within a year

 

$

5,893

 

 

$

(92

)

 

$

-

 

 

$

-

 

 

$

98

 

 

$

-

 

Due after one year

 

 

11,991

 

 

 

(415

)

 

 

591

 

 

 

(3

)

 

 

-

 

 

 

-

 

Total

 

$

17,884

 

 

$

(507

)

 

$

591

 

 

$

(3

)

 

$

98

 

 

$

-

 

 

Summary of Changes in Contingent Consideration The following table presents the changes in the contingent consideration (in millions):

 

 

Nine-Month Period

 

 

Ended September 30,

 

 

2023

 

 

2022

 

Beginning balance

$

63.8

 

 

$

114.9

 

Additions from acquisitions

 

1.8

 

 

 

-

 

Payments to sellers

 

(35.1

)

 

 

(65.3

)

(Gain) loss recognized in earnings

 

(8.9

)

 

 

6.8

 

Ending balance

$

21.6

 

 

$

56.4

 

 

As of September 30, 2023 the contingent liability fair value was included in the Condensed Consolidated Balance Sheets in the amount of $8.2 million as a current liability within Accounts payable and accrued expenses, and $13.4 million as a noncurrent liability within Other long-term liabilities.

Summary of Components of AOCI

The following table provides a roll-forward of accumulated other comprehensive income (loss) (in thousands):

 

 

 

Foreign
Currency
Translation

 

 

Marketable
Securities

 

 

Total

 

Accumulated other comprehensive income (loss) as of December 31, 2022

 

$

(1,345

)

 

$

(165

)

 

$

(1,510

)

Other comprehensive income (loss)

 

 

16

 

 

 

138

 

 

 

154

 

Income tax (expense) benefit

 

 

-

 

 

 

(35

)

 

 

(35

)

Amounts reclassified from AOCI

 

 

-

 

 

 

31

 

 

 

31

 

Income tax (expense) benefit

 

 

-

 

 

 

(8

)

 

 

(8

)

Other comprehensive income (loss), net of tax

 

 

16

 

 

 

126

 

 

 

142

 

Accumulated other comprehensive income (loss) as of March 31, 2023

 

 

(1,329

)

 

 

(39

)

 

 

(1,368

)

Other comprehensive income (loss)

 

 

(71

)

 

 

106

 

 

 

35

 

Income tax (expense) benefit

 

 

-

 

 

 

(27

)

 

 

(27

)

Amounts reclassified from AOCI

 

 

-

 

 

 

29

 

 

 

29

 

Income tax (expense) benefit

 

 

-

 

 

 

(7

)

 

 

(7

)

Other comprehensive income (loss), net of tax

 

 

(71

)

 

 

101

 

 

 

30

 

Accumulated other comprehensive income (loss) as of June 30, 2023

 

 

(1,400

)

 

 

62

 

 

 

(1,338

)

Other comprehensive income (loss)

 

 

(408

)

 

 

(11

)

 

 

(419

)

Amounts reclassified from AOCI

 

 

-

 

 

 

33

 

 

 

33

 

Income tax (expense) benefit

 

 

-

 

 

 

(5

)

 

 

(5

)

Other comprehensive income (loss), net of tax

 

 

(408

)

 

 

17

 

 

 

(391

)

Accumulated other comprehensive income (loss) as of September 30, 2023

 

 

(1,808

)

 

 

79

 

 

 

(1,729

)